Yu Min Liao

Summary

Publications

  1. pmc Mammalian target of rapamycin and head and neck squamous cell carcinoma
    Yu Min Liao
    Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
    Head Neck Oncol 3:22. 2011
  2. ncbi request reprint Markers for efficacy of mammalian target of rapamycin inhibitor
    Yu Min Liao
    Division of Medical Oncology and Hematology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan, ROC
    Anticancer Res 32:4235-44. 2012
  3. pmc Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease
    Su Peng Yeh
    Stem Cell Research Lab, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan
    PLoS ONE 7:e44416. 2012
  4. doi request reprint OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis
    Li Yuan Bai
    Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude Road, Taichung 40402 Taiwan College of Medicine, School of Medicine, China Medical University, 91, Hsueh Shih Road, Taichung 40402 Taiwan Electronic address
    Biochem Pharmacol 86:1430-40. 2013
  5. doi request reprint Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3
    Po Han Lin
    Department of Medical Genetics, China Medical University Hospital, Taichung, Taiwan
    Leuk Res 37:287-92. 2013
  6. ncbi request reprint Fusidic acid-induced leukopenia and thrombocytopenia
    Yu Min Liao
    Division of Hematology Oncology, Department of Internal Medicine, China Medical College Hospital, Taichung, Taiwan, ROC
    J Chin Med Assoc 66:429-32. 2003
  7. doi request reprint Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cells
    Su Peng Yeh
    Stem Cell Research Lab, Department of Medical Research, China Medical University Hospital, 2 Yuh Der Road, Taichung, 404, Taiwan
    Ann Hematol 91:163-72. 2012

Collaborators

  • Su Peng Yeh
  • Li Yuan Bai
  • Chang Fang Chiu
  • Po Han Lin
  • Chen Yuan Lin
  • Ching Yun Hsieh
  • Wen Jyi Lo
  • Chiao Lin Lin
  • Ching Chan Lin
  • Fuu Jen Tsai
  • Cheng Mao Ho
  • Chia Yung Wu
  • Ching Tien Peng
  • Long Yuan Li
  • Jing Ru Weng
  • Aaron M Sargeant
  • Chien Yu Lin
  • Hwai I Yang
  • Shu Fen Yang
  • Yu Ting Huang
  • Ji An Liang
  • Yu Chien Chang

Detail Information

Publications7

  1. pmc Mammalian target of rapamycin and head and neck squamous cell carcinoma
    Yu Min Liao
    Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
    Head Neck Oncol 3:22. 2011
    ..We have reviewed the pathogenesis of HNSCC, mTOR pathway, mTOR inhibitor and the role of mTOR in HNSCC...
  2. ncbi request reprint Markers for efficacy of mammalian target of rapamycin inhibitor
    Yu Min Liao
    Division of Medical Oncology and Hematology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan, ROC
    Anticancer Res 32:4235-44. 2012
    ..We discuss these potential markers in terms of selection of candidates, baseline expression, pathway inhibition and source of targeted protein...
  3. pmc Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease
    Su Peng Yeh
    Stem Cell Research Lab, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan
    PLoS ONE 7:e44416. 2012
    ..The causal relationship between kinetics of Th1, Th2 and associated cytokines and the clinical activity of GVHD in a real world situation remains unknown...
  4. doi request reprint OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis
    Li Yuan Bai
    Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude Road, Taichung 40402 Taiwan College of Medicine, School of Medicine, China Medical University, 91, Hsueh Shih Road, Taichung 40402 Taiwan Electronic address
    Biochem Pharmacol 86:1430-40. 2013
    ..This study shows that ROS-mediated apoptosis contributes to the anticancer activity of OSU-A9 in AML cell lines and primary AML cells, and thus should be considered in the future assessment of its translational value in AML therapy. ..
  5. doi request reprint Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3
    Po Han Lin
    Department of Medical Genetics, China Medical University Hospital, Taichung, Taiwan
    Leuk Res 37:287-92. 2013
    ..This result indicated that patients with FLT3-ITD/nonHSCT had a significantly worse outcome, but allogeneic HSCT improved the prognosis for patients with FLT3-ITD...
  6. ncbi request reprint Fusidic acid-induced leukopenia and thrombocytopenia
    Yu Min Liao
    Division of Hematology Oncology, Department of Internal Medicine, China Medical College Hospital, Taichung, Taiwan, ROC
    J Chin Med Assoc 66:429-32. 2003
    ..We recommend periodic complete blood count check in patients receiving long-term fusidic acid treatment to avoid serious hematological adverse effects...
  7. doi request reprint Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cells
    Su Peng Yeh
    Stem Cell Research Lab, Department of Medical Research, China Medical University Hospital, 2 Yuh Der Road, Taichung, 404, Taiwan
    Ann Hematol 91:163-72. 2012
    ..TBI especially exerts detrimental effect on the chromosomal integrity of BM-MSCs and highlights the equal importance of investigating long-term adverse effect of anti-leukemic therapy on BM-MSCs as opposed to beneficial effect on BM-HCs...